Redefining Antiviral Defense & Enzyme Innovation
Material Bios Inc. is building advanced plant-based bioencapsulation platforms for research-stage human therapeutics, animal health applications, and industrial enzymes.
Where Plant Science Meets Global Impact
Material Bios Inc. specializes in plant molecular biology, leveraging proprietary platforms to develop novel solutions across human health, animal agriculture, and sustainable energy. Our foundation is a unique family of carbohydrate-binding lectins — including the revolutionary FRIL — isolated from the hyacinth bean.
FRIL-based broad-spectrum viral-binding research targeting influenza, coronaviruses, and emerging pathogens with reported in-vitro activity.
Plant-derived cellulase and xylanase systems for biofuel processing, feed optimization, and industrial biotransformation.
Bio-enhanced feed additives and plant-based immune boosters for poultry and livestock, reducing antibiotic dependency.
Meet FRIL.
Nature’s ultimate biological shield.
FRIL is a groundbreaking broad-spectrum antiviral lectin derived from the hyacinth bean. By targeting and binding to complex glycans on the surface of viruses, it acts as a molecular lock—physically preventing viral entry into host cells with extraordinary precision.
FRIL targets high-mannose glycan structures (Man5–Man9) on viral surface proteins, creating a physical blockade that prevents host cell fusion. Unlike conventional antivirals that target specific viral proteins, FRIL targets conserved glycan structures — making resistance extremely unlikely.
Simulated dose-response based on published in-vitro IC50/IC90 data.
Influenza A & B: Published cell-based assays report up to 99.9% neutralization of selected H1N1, H3N2, and Influenza B strains.
Coronaviruses: Research describes SARS-CoV-2 spike glycoprotein binding and ACE2 receptor-engagement inhibition across studied variants.
Safety: Hyacinth bean materials and related regulatory pathways require product-specific review before commercialization.
Delivery: Oral, intranasal, and aerosolized routes have been explored in research contexts and require further validation.
The future of Enzymes.
Grown in plants.
By leveraging plant chloroplasts as natural bioreactors, we achieve massively scalable, highly stable enzyme production—bypassing the extreme costs and limitations of traditional microbial fermentation.
Cellulase systems convert corn stover, switchgrass, and agricultural waste into fermentable sugars at higher yields than conventional fungal enzymes — enabling cost-effective second-generation biofuel.
Xylanase supplements improve nutrient absorption in poultry and livestock by breaking down anti-nutritional factors. Trials with WVU and University of Delaware showed measurable feed conversion improvements.
Applications in textile processing, paper & pulp, and specialty chemical synthesis — eco-friendly alternatives operating at milder conditions with lower energy consumption.
Simulating billions of molecular permutations requires immense computational power. We leverage multithreaded Web Workers to offload these heavy calculations from the main thread, ensuring the interface remains flawlessly responsive.
The Architects of Agricultural Innovation
Portfolio entrepreneur, investor, and community leader with experience across retail, real estate, technology, renewable energy, and public service...
Veterinarian with 36+ years of global experience across technical services, innovation, R&D, regulatory, marketing, and business leadership...
W.D. Miller Professor at University of Pennsylvania. Pioneered oral delivery of affordable biopharmaceuticals, enzymes, and antiviral research programs via plant molecular biotechnology...
Director of the University of Delaware Poultry Health System, focusing on respiratory viruses and avian vaccination programs...
Professor of Poultry Nutrition and Feed Manufacture. Nationally renowned expert in feed formulation for chicken and turkey studies...
Strategic Partners
Collaborative research on avian influenza and FRIL application in poultry health, including viral-load and immune-response endpoints.
Enzyme feed trial partnerships evaluating xylanase supplementation effects on poultry growth and feed efficiency.
Engagement with USDA-ARS laboratories and applicable regulatory pathways for agricultural product review.
Let's Build the Future Together
Research partner, investor, or innovator — we'd love to hear from you.
Get in Touch